Brief: Nightingale Reports H1 EBITDA Of EUR -5.37 Million
05/03/2026 08:11
March 5 (Reuters) - Nightingale Health Oyj HEALTH.HE: NIGHTINGALE HEALTH'S HALF-YEAR REPORT: DELIVERING CLINICAL VALUE FOR HEALTHCARE AND MOVING TOWARD 50% REVENUE GROWTH, SUPPORTED BY A STRONG SALES PIPELINE JULY-DEC 2025 REVENUE EUR 2.41 MILLION JULY-DEC 2025 EBITDA EUR -5.37 MILLION Source text: ID:nMFN2Bmb5S Further company coverage: HEALTH.HE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Nightingale Health Oyj
See all newsBrief: Nightingale And The Private GP Group Enter Agreement
Brief: Siun Sote To Pilot Nightingale Health Risk Detection
Brief: Nightingale Enters Into Service Agreement In Latvia
Brief: Nightingale Health And Archipelago Health Sign Deal In Carribean, Bermuda
Finland's Nightingale Health annual revenue rises on expansion of commercial team